Doubts on suicide-anti-smoking drug Chantix link

	Tweet

Despite earlier health agency warnings, there is no strong evidence that the anti-smoking drug Chantix raises the risk of suicidal thoughts or depression compared to other stop-smoking products, researchers reported Thursday in the British Medical Journal.

Back in July of this year, U.S. health officials ordered strong “black box” warnings be added to Chantix (also called varenicline) as well as anti-smoking drug Zyban, following more than five thousand reports of depression, hostility and other behavioral changes possibly associated with use of these drugs.

“There have been recent concerns that varenicline, a relatively new smoking cessation product, may increase the risk of suicidal behaviour and suicide,” study co-author Dr. David Gunnell of the University of Bristol, UK, explained in an email to Reuters Health.

"We found no clear evidence of an increased risk of self-harm or depression associated with varenicline,” he said.

The findings stem from data on more than 80,660 would-be quitters in the UK who used different smoking cessation products between September 2006 and May 2008.

A total of 63,265 of these individuals used nicotine replacement products, 10,973 used Chantix, and 6,422 used Zyban, an antidepressant also called bupropion, which has been found to help smokers quit.

When researchers looked at medical records, they didn’t find any evidence of an increased risk of serious mental health problems (i.e., self-harm, suicidal thoughts or depression) while they were using these products and during the three months after the last prescription was filled.

Gunnell cautioned, however, that based on the size of the study, it’s still possible that Chantix does increase the risk of suicide - or even decrease it.

“Other studies should be undertaken to provide further evidence on this issue,” he concluded.

The study was funded by a grant from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA).

SOURCE: British Medical Journal, online October 2, 2009.

RELATED STORIES:
Other Vioxx-like drugs also risky for heart   Intercell kills diarrhea vaccine after study   Ibuprofen puts high risk cardiac patients at risk   Birth control pill poses no added health risk   US Medicare to help look for drug side effect   FDA warns of allergy risk with Merck antipsychotic   Boozy Britain wary of ‘anti-hangover pill’   Misuse of ADHD drugs sends thousands each year to seek emergency hospital treatment   Computers no cure-all for medical errors - study   Autism-vaccine researcher a “fraud”: medical journal   California drug offenders lapse despite rehab   Drug used worldwide doubles risk of kidney failure

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]